This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Elpiscience (Suzhou) Biopharma, Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Robert H Arch - Innovator in Biopharmaceuticals
Introduction
Robert H Arch is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative work on anti-CD39 antibodies. His research has the potential to impact various therapeutic applications.
Latest Patents
Robert H Arch holds a patent for anti-CD39 antibodies. This patent includes anti-CD39 antibodies or antigen-binding fragments, isolated polynucleotides encoding the same, pharmaceutical compositions comprising these antibodies, and their uses. This innovation represents a crucial advancement in the development of targeted therapies.
Career Highlights
Robert H Arch is currently associated with Elpiscience (Suzhou) Biopharma, Ltd. His work at this company focuses on developing novel biopharmaceutical products that address unmet medical needs. His expertise in antibody development has positioned him as a key figure in the biopharmaceutical industry.
Collaborations
Robert has collaborated with notable colleagues, including Yangsheng Qiu and Meiling Sun. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapies.
Conclusion
Robert H Arch's contributions to the field of biopharmaceuticals, particularly through his patent on anti-CD39 antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted therapies.